ImmunoCAP
The way to precisely measure IgE antibodies - and we can prove it!
Technical excellence - the only way to provide clinically useful results
Allergic diseases are a rapidly growing health problem. A precise, reliable in vitro test for IgE antibodies to specific substances is a valuable tool to support the clinician in making diagnoses of or excluding allergy, prescribing and following up treatment, and predicting disease development.
Correct and precise results - the firm basis for clinical diagnosis
Only a test system consistently giving correct results is a suitable clinical tool. Traditionally IgE antibody test results have been reported as positive/negative or in classes. Even this broad classification of IgE sensitivity requires a very good test precision, in order to accurately determine if a sample falls above or below the stipulated cut-off value or within a certain class.
Correct and precise results - the prerequisite for obtaining more information
In order to understand an evolving allergic disease it is necessary to gain more detailed information about the ongoing IgE sensitization process in the patient. Such accurate information can only be obtained through quantitative measurements of the levels of IgE antibodies to different allergens in the blood.
ImmunoCAP - the truly quantitative IgE antibody test
For a truly quantitative antibody IgE test giving the results in kU A /l rather than in classes, the requirements for accuracy are even higher.
Technical as well as clinical data confirm that ImmunoCAP from Phadia is a test system excellent for the precise and correct measurement of IgE antibodies in relation to clinical disease. Consequently, ImmunoCAP is a suitable tool for supporting clinicians in the evaluation of allergic patients.